Article info

Download PDFPDF
Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas

Authors

  1. Correspondence to Dr. Guillaume Le Guyader, Pharmacy Department, Henri Mondor Hospital Group, Créteil 94010, France; leguyader.guillaume{at}gmail.com
View Full Text

Citation

Le Guyader G, Vieillard V, Andrieux K, et al
Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas

Publication history

  • Received July 25, 2018
  • Revised October 4, 2018
  • Accepted October 9, 2018
  • First published November 10, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.